GOOG

296.77

-2.33%↓

GOOG.US

293.91

-2.37%↓

META.US

597.14

-1.27%↓

NFLX

92.59

-0.58%↓

TMUS

212.27

+1.7%↑

GOOG

296.77

-2.33%↓

GOOG.US

293.91

-2.37%↓

META.US

597.14

-1.27%↓

NFLX

92.59

-0.58%↓

TMUS

212.27

+1.7%↑

GOOG

296.77

-2.33%↓

GOOG.US

293.91

-2.37%↓

META.US

597.14

-1.27%↓

NFLX

92.59

-0.58%↓

TMUS

212.27

+1.7%↑

GOOG

296.77

-2.33%↓

GOOG.US

293.91

-2.37%↓

META.US

597.14

-1.27%↓

NFLX

92.59

-0.58%↓

TMUS

212.27

+1.7%↑

GOOG

296.77

-2.33%↓

GOOG.US

293.91

-2.37%↓

META.US

597.14

-1.27%↓

NFLX

92.59

-0.58%↓

TMUS

212.27

+1.7%↑

Search

Arq Inc

Open

SectorIndustrials

2.32 5.94

Overview

Share price change

24h

Current

Min

2.05

Max

2.36

Key metrics

By Trading Economics

Income

1.5M

-653K

Sales

6.5M

35M

P/E

Sector Avg

0.743

61.065

Profit margin

-1.862

Employees

128

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+188.94% upside

Dividends

By Dow Jones

Next Earnings

6 maj 2026

Market Stats

By TradingEconomics

Market Cap

-32M

34M

Previous open

-3.62

Previous close

2.32

News Sentiment

By Acuity

34%

66%

115 / 406 Ranking in Industrials

Technical Score

By Trading Central

Confidence

Neutral Evidence

Arq Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

23 mar 2026, 23:47 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences to Buy Ouro Medicines, Collaborate With Galapagos on Purchased Assets -- Update

23 mar 2026, 22:55 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences to Buy Ouro Medicines for Up to $2.18 Billion

23 mar 2026, 21:51 UTC

Acquisitions, Mergers, Takeovers

Italy's Postal Service Makes $12.50 Billion Bid for Telecom Italia -- 3rd Update

23 mar 2026, 23:59 UTC

Market Talk

Global Equities Roundup: Market Talk

23 mar 2026, 23:59 UTC

Market Talk

Woodside, Santos Earnings Power Up on Surging LNG Prices -- Market Talk

23 mar 2026, 23:50 UTC

Market Talk

Nikkei May Rise on Hopes for U.S. Talks With Iran -- Market Talk

23 mar 2026, 23:37 UTC

Market Talk

Gold Rises, Boosted by Fall in Dollar, U.S. Treasury Yields -- Market Talk

23 mar 2026, 22:42 UTC

Market Talk
Major News Events

Global Equities Roundup: Market Talk

23 mar 2026, 22:42 UTC

Market Talk
Major News Events

Bell Potter Names Miners Less Exposed to Fuel Price, Supply Risks -- Market Talk

23 mar 2026, 22:40 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences to Buy Ouro Medicines for Up to $2.18B

23 mar 2026, 22:23 UTC

Market Talk

Apollo Debt Solutions Shrugs Off Private-Credit Fears -- Market Talk

23 mar 2026, 22:22 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences: OM336 Is for Treatment of Autoantibodies Driven Immune-Mediated Disease

23 mar 2026, 22:21 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences: Company Would Pay Galapagos Royalties of 20%-23% of Net OM336 Sales

23 mar 2026, 22:21 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences: Company Would Retain Sole Worldwide Commercialization Rights of OM336 Outside of Greater China

23 mar 2026, 22:20 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences: Company, Galapagos Would Collaborate on Development of OM336 >GILD

23 mar 2026, 22:20 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences: Galapagos Would Absorb Substantially All of Ouro's Operating Assets, Retain Its Employees >GILD

23 mar 2026, 22:19 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences: Galapagos Would Pay 50% of Upfront Consideration and 50% of Any Contingent Milestone Payments Payable to Ouro Shareholders

23 mar 2026, 22:19 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences: Currently in Advanced Discussions With Galapagos With Respect to Potential Research-and-Development Collaboration on Acquired Ouro Assets

23 mar 2026, 22:18 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences to Buy Ouro Medicines for About $1.68B Upfront, Up to $500M in Contingent Milestone Payments >GILD

23 mar 2026, 22:15 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences To Acquire Ouro Medicines To Advance First In Class T Cell Engager Program For Autoimmune Diseases >GILD

23 mar 2026, 22:08 UTC

Market Talk

Ebos Needs to Reset Its Gearing Targets -- Market Talk

23 mar 2026, 21:42 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

23 mar 2026, 21:42 UTC

Market Talk

RBNZ's Breman Strikes Reassuring Tone On Rates -- Market Talk

23 mar 2026, 21:32 UTC

Earnings

WuXi XDC Cayman: Results Aided by Strong Growth in Contract Research, Development and Manufacturing Organisation Business>2268.HK

23 mar 2026, 21:32 UTC

Earnings

WuXi XDC Cayman 2025 Net CNY1.56B Vs. Net CNY917.16M >2268.HK

23 mar 2026, 21:32 UTC

Earnings

WuXi XDC Cayman 2025 Rev CNY5.94B Vs. CNY4.05B >2268.HK

23 mar 2026, 21:10 UTC

Major News Events

Oil Is Back Under $100. Trump Says Iran Has Agreed to No Nuclear Weapons. -- Barrons.com

23 mar 2026, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

23 mar 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

23 mar 2026, 20:50 UTC

Market Talk
Earnings
Major News Events

Basic Materials Roundup: Market Talk

Peer Comparison

Price change

Arq Inc Forecast

Price Target

By TipRanks

188.94% upside

12 Months Forecast

Average 5.75 USD  188.94%

High 6.5 USD

Low 5 USD

Based on 3 Wall Street analysts offering 12 month price targets forArq Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

3 ratings

3

Buy

0

Hold

0

Sell

Technical Score

By Trading Central

3.12 / 3.26Support & Resistance

Short Term

Neutral Evidence

Intermediate Term

Bullish Evidence

Long Term

Very Strong Bearish Evidence

Sentiment

By Acuity

115 / 406 Ranking in Industrials

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Arq Inc

Advanced Emissions Solutions, Inc., together with its subsidiaries, provides emission reduction technologies and specialty chemicals in the United States. It operates through two segments, Refined Coal; and Power Generation and Industrials. The company offers CyClean technology, a pre-combustion coal treatment process to enhance combustion, as well as to reduce emissions of nitrogen oxide and mercury from coals burned in cyclone boilers; and M-45 and M-45-PC technologies, which are pre-combustion coal treatment technologies used to control emissions from circulating fluidized bed boilers and pulverized coal boilers. It also provides powdered activated carbon, granular activated carbon, coal additives, and scrubber additives, as well as owns an associated lignite mine that supplies the raw material for the powdered activated carbon plant. The company serves customers in the coal-fired power generation and industrial boiler processes, as well as potable water and wastewater treatment markets. Advanced Emissions Solutions, Inc. was founded in 1996 and is headquartered in Highlands Ranch, Colorado.
help-icon Live chat